Exploration of liver cancer genomes

@article{Shibata2014ExplorationOL,
  title={Exploration of liver cancer genomes},
  author={Tatsuhiro Shibata and Hiroyuki Aburatani},
  journal={Nature Reviews Gastroenterology \&Hepatology},
  year={2014},
  volume={11},
  pages={340-349}
}
Liver cancer is the third leading cause of cancer-related death worldwide. Advances in sequencing technologies have enabled the examination of liver cancer genomes at high resolution; somatic mutations, structural alterations, HBV integration, RNA editing and retrotransposon changes have been comprehensively identified. Furthermore, integrated analyses of trans-omics data (genome, transcriptome and methylome data) have identified multiple critical genes and pathways implicated in… 
Heterogeneity of Hepatocellular Carcinoma
TLDR
The international collaborations of cancer genome sequencing projects are expected to contribute to an improved understanding of risk assessment, diagnosis and therapy for Hepatocellular carcinoma.
Biological features and biomarkers in hepatocellular carcinoma.
TLDR
This review focuses on the recent developments in molecular cancer research on HCC and explains the biological features and novel biomarkers.
Epigenetic landscape influences the liver cancer genome architecture
TLDR
It is concluded that both precancerous and somatic epigenetic features contribute to the cancer genome architecture as well as genetic aberrations including somatic substitutions, mutation signatures, and HBV integration sites.
Genetic alterations in hepatocellular carcinoma: An update
TLDR
The current advances in research on the genetic alterations, including genomic instability, single-nucleotide polymorphisms, somatic mutations and deregulated signaling pathways, implicated in the initiation and progression of HCC are summarized.
Epigenetic dysregulation in hepatocellular carcinoma: an up‐to‐date review
TLDR
The importance of epigenetic regulation can be observed from the high rate of genetic mutations and abnormal gene expression leading to a breakdown in epigenetic gene expression regulation seen in hepatocellular carcinoma (HCC).
Molecular genomic landscapes of hepatobiliary cancer
TLDR
Integrative analyses of multi‐omics data identified molecular classifications of these tumors that are associated with clinical outcome and enrichments of potential therapeutic targets, including immune checkpoint molecules.
Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method
TLDR
It was observed that extracellular signals were further transduced to transcription factors (TFs), resulting in the aberrant regulation of their target genes, in turn inducing mechanisms that are responsible for HCC progression, including cell proliferation, anti-apoptosis, aberrant cell cycle, cell survival, and metastasis.
Genomic alterations across six hepatocellular carcinoma cell lines by panel-based sequencing
TLDR
The authors' panel-based sequencing analysis of HCC cell lines identified genomic alterations in HCC experimental cellular models as well as the mutational patterns of cells from different and same clone origins, providing new insights into the understanding of genetic heterogeneity and clonal evolution of liver cancer.
DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma
TLDR
Insight is provided into the roles of the retromer complex on carcinogenesis and has important implications for the development of personalized therapeutic strategies for LIHC.
Mechanisms of Disease: The Damaged Genome in HCC
TLDR
This review summarises recent data investigating the genetic predisposition to HCC development, mechanisms of genome injury in HCC and the findings of large-scale sequencing projects in H CC that have transformed the understanding of the pathogenesis.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 125 REFERENCES
Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators
TLDR
The whole-genome sequencing analysis of HCCs identified the influence of etiological background on somatic mutation patterns and subsequent carcinogenesis, as well as recurrent mutations in chromatin regulators in H CCs.
Hepatocellular carcinoma: transcriptome diversity regulated by RNA editing.
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
TLDR
Findings from a whole-genome sequencing study of 88 matched HCC tumor/normal pairs, 81 of which are Hepatitis B virus (HBV) positive, find beta-catenin to be the mostrequently mutated oncogene and TP53 the most frequently mutated tumor suppressor.
Identification of driver genes in hepatocellular carcinoma by exome sequencing
TLDR
The NFE2L2‐KEAP1 and MLL pathways are recurrently mutated in multiple cohorts of HCC, with significantly affected gene families include the nucleotide‐binding domain and leucine‐rich repeat‐containing family, calcium channel subunits, and histone methyltransferases.
Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
TLDR
In vitro and in vivo analyses indicated that the products of PROSC, SH2D4A, and SORBS3 have tumor-suppressive activities, along with the known tumor suppressor gene DLC1.
Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma
TLDR
It is demonstrated that characterizing the CNA landscape in HCC will facilitate the understanding of disease mechanisms and the identification of oncogenic drivers that may serve as potential therapeutic targets for the treatment of this devastating disease.
Genetic Alterations and Oncogenic Pathways in Hepatocellular Carcinoma
TLDR
This search might shed some light on the tumorigenic role of HBV and HCV and permit accurate evaluation of major targets for prognostic and therapeutic intervention.
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
TLDR
Functional analyses showed tumor suppressor properties for IRF2, whose inactivation, exclusively found in hepatitis B virus-related tumors, led to impaired TP53 function, and association of mutations in specific genes suggested that Wnt/β-catenin signaling might cooperate in liver carcinogenesis with both oxidative stress metabolism and Ras/mitogen-activated protein kinase (MAPK) pathways.
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
TLDR
This classification has potential therapeutic implications because 50% of the tumors were related to WNT or AKT pathway activation, which potentially could be targeted by specific inhibiting therapies, and has provided specific identifiers for classifying tumors.
...
1
2
3
4
5
...